NOTES FROM
THE PHARMACEUTICAL INDUSTRY
SECTOR


According to free market and tender data of IMS Health, 2,211 million boxes worth TL 19 Billion (*) were sold in Turkish Pharmaceutical Market in 2015. The market achieved growth at a rate of 7.42% in number of boxes and at a rate of 16.78% in TL compared with the previous year.

 

Rate of prescription drugs to total pharmaceutical market in Turkish market is 92% both in number of boxes and TL.

 

Although drugs from many treatment groups are imported in our country, preparations requiring new and advanced technology, some vaccines, blood factors, some controlled-release drugs, respiratory, insulin, and anti-cancer drugs are predominantly imported.

According to IMS Health data, the sector’s import increased by 7.1% on a box basis; however, it decreased by 5.5%, remaining at USD 4.1 billion on USD basis. The domestic pharmaceutical market grew by 7.5 on a box basis; however, it shrank by 6.5%, remaining at USD 2.8 billion on USD basis. The rate of import to the total pharmaceutical market is 25% on a box basis and 60% on USD basis.

 

According to IMS Health data, the sector grew by 7.4 on a box basis; however it shrank by 5.9 on USD basis, remaining at USD6.9 billion. The total pharmaceutical market reached TL 19 billion, with a growth of 16.8.

Market distribution according to drug segments in our country in 2015 took place on box and TL/USD basis as follows. On both box and TL/USD basis, Nutrition & Metabolism segment has the biggest share

(*) “Surplus Goods” are included in the value in boxes but not included in the value in TL depending on the change in the calculation method of the IMS.